The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
The Evolution of Melanoma Diagnosis: 25 Years Beyond the ABCDs
Open accessAbstract
Early detection of malignant melanoma remains the key factor in lowering mortality from this cancer. Recognizing the importance of this issue 25 years ago, our group at New York University published in CA: A Cancer Journal for Clinicians the mnemonic "ABCD" to facilitate the early diagnosis of melanoma. Studies have demonstrated the usefulness of this paradigm in enhancing early melanoma diagnosis as a part of clinical examinations, mass screenings, and public education programs. Approaches to melanoma diagnosis have dynamically evolved during the ensuing quarter century. In the 1990s, dermoscopy enabled the recognition of new subsurface features to differentiate between malignant and benign pigmented lesions. During the last decade, new computer-based technologies have improved diagnostic sensitivity and specificity and may result in optimizing lesion selection for biopsy and pathology review. Despite all of the advances in melanoma diagnosis, timely recognition, detection, and rapid treatment of melanoma remain critical. Although pathologic examination remains the gold standard for diagnosis, this cancer has the potential to be diagnosed through noninvasive approaches because of its cutaneous location. From the development of the ABCDs through current attempts that use complex computer algorithms and genetic markers, a clinician's ability to detect melanoma in its earliest form has been augmented. However, a "good clinical eye" is still fundamental to selecting the lesions for evaluation among the sea of those that are prevalent. As current approaches are refined and new techniques are developed, the improved ability to diagnose this cancer will hopefully enhance reaching the goal of reducing melanoma mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Balch, C. M., Soong, S.-J., Gershenwald, J. E., Thompson, J. F., Reintgen, D. S., Cascinelli, N., Urist, M., McMasters, K. M., Ross, M. I., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3622 · Cited by 2,388
Model Predicting Survival in Stage I Melanoma Based on Tumor Progression
Clark, W. H., Elder, D. E., Guerry, D., Braitman, L. E., Trock, B. J., Schultz, D., Synnestvedt, M., & Halpern, A. C. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1893 · Cited by 1,247
Dermoscopy of pigmented skin lesions: Results of a consensus meeting via the Internet
Argenziano, G., Soyer, H. P., Chimenti, S., Talamini, R., Corona, R., Sera, F., Binder, M., Cerroni, L., De Rosa, G., Ferrara, G., et al. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.281 · Cited by 1,208
Vestergaard, M. E., Macaskill, P., Holt, P. E., & Menzies, S. W. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08713.x · Cited by 862
Friedman, R. J., Rigel, D. S., & Kopf, A. W. (1985) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.35.3.130 · Cited by 844
Self-citationRajadhyaksha, M., González, S., Zavislan, J. M., Rox Anderson, R., & Webb, R. H. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00690.x · Cited by 834
Increasing Burden of Melanoma in the United States
Linos, E., Swetter, S. M., Cockburn, M. G., Colditz, G. A., & Clarke, C. A. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.423 · Cited by 746
Early Diagnosis of Cutaneous Melanoma: Revisiting the ABCD Criteria
Abbasi, N. R., Shaw, H. M., Rigel, D. S., Friedman, R. J., McCarthy, W. H., Osman, I., Kopf, A. W., & Polsky, D. (2004) · JAMA · doi:10.1001/jama.292.22.2771 · Cited by 668
Self-citationBafounta, M.-L., Beauchet, A., Aegerter, P., & Saiag, P. (2001) · Archives of Dermatology · doi:10.1001/archderm.137.10.1343 · Cited by 505
Malignant melanoma: prevention, early detection, and treatment in the 21st century
Rigel, D. S., & Carucci, J. A. (2000) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.50.4.215 · Cited by 461
Self-citation
Cited by
ACG clinical guideline: Preventive care in inflammatory bowel disease
Farraye, F. A., Melmed, G. Y., Lichtenstein, G. R., & Kane, S. V. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.537 · Cited by 473
Ultraviolet Radiation, Aging and the Skin: Prevention of Damage by Topical cAMP Manipulation
Amaro-Ortiz, A., Yan, B., & D'Orazio, J. (2014) · Molecules · doi:10.3390/molecules19056202 · Cited by 360
Good News–Bad News: The Yin and Yang of Immune Privilege in the Eye
Forrester, J. V., & Xu, H. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00338 · Cited by 153
Loss of microRNA-205 expression is associated with melanoma progression
Liu, S., Tetzlaff, M. T., Liu, A., Liegl-Atzwanger, B., Guo, J., & Xu, X. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.62 · Cited by 74
Chen, J. Y., Fernandez, K., Fadadu, R. P., Reddy, R., Kim, M.-O., Tan, J., & Wei, M. L. (2025) · JAMA Dermatology · doi:10.1001/jamadermatol.2024.4382 · Cited by 43
Metadata
- Authors
- Rigel, D. S., Russak, J., & Friedman, R.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2010-07-29
- Volume
- 60
- Issue
- 5
- Pages
- 301-316
- ISSN
- 0007-9235 (ISSN-L)
- OpenAlex
- W2166664821
- Cited by
- 420
- References
- 87
- FWCI
- 12.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Evolution of Melanoma Diagnosis: 25 Years Beyond the ABCDs. https://app.cochat.ai/papers/10.3322/caac.20074
- The paper
- Rigel, D. S., Russak, J., & Friedman, R. (2010). The Evolution of Melanoma Diagnosis: 25 Years Beyond the ABCDs. CA: A Cancer Journal for Clinicians. https://doi.org/10.3322/caac.20074
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
